• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

胆固醇代谢与肿瘤治疗的研究进展

Research progress on cholesterol metabolism and tumor therapy.

作者信息

Chu Zewen, Fang Lei, Xiang Yanwei, Ding Yue

机构信息

School of Rehabilitation Science, Shanghai University of Traditional Chinese Medicine, Shanghai, 201203, China.

Institute of Rehabilitation Medicine, Shanghai Academy of Traditional Chinese Medicine, Shanghai, 201203, China.

出版信息

Discov Oncol. 2025 Apr 30;16(1):647. doi: 10.1007/s12672-025-02430-5.

DOI:10.1007/s12672-025-02430-5
PMID:40307614
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12043555/
Abstract

Cholesterol and its metabolic derivatives have important biological functions and are crucial in tumor initiation, progression, and treatment. Cholesterol maintains the physical properties of cellular membranes and is pivotal in cell signal transduction. Cholesterol metabolism includes both de novo synthesis and uptake from extracellular sources such as low-density lipoprotein (LDL) and high-density lipoprotein (HDL). This review explores both aspects to provide a comprehensive understanding of their roles in cancer. Cholesterol metabolism is involved in bile acid production and steroid hormone biosynthesis and is closely linked to the reprogramming of endogenous and exogenous cellular signals within the tumor microenvironment. These signals are intricately associated with key biological processes such as tumor cell proliferation, survival, invasion, and metastasis. Evidence suggests that regulating cholesterol metabolism may offer therapeutic benefits by inhibiting tumor growth, remodeling the immune microenvironment, and enhancing antitumor immune responses. This review summarizes the role of cholesterol metabolism in tumor biology and discusses the application of statins and other cholesterol metabolism inhibitors in cancer therapy, aiming to provide novel insights for the development of antitumor drugs targeting cholesterol metabolism and for advances in cancer diagnosis and treatment.

摘要

胆固醇及其代谢衍生物具有重要的生物学功能,在肿瘤的发生、发展和治疗中起着关键作用。胆固醇维持细胞膜的物理性质,在细胞信号转导中起关键作用。胆固醇代谢包括从头合成以及从细胞外来源如低密度脂蛋白(LDL)和高密度脂蛋白(HDL)摄取。本综述探讨了这两个方面,以全面了解它们在癌症中的作用。胆固醇代谢参与胆汁酸生成和类固醇激素生物合成,并与肿瘤微环境中内源性和外源性细胞信号的重编程密切相关。这些信号与肿瘤细胞增殖、存活、侵袭和转移等关键生物学过程错综复杂地相关。有证据表明,调节胆固醇代谢可能通过抑制肿瘤生长、重塑免疫微环境和增强抗肿瘤免疫反应而带来治疗益处。本综述总结了胆固醇代谢在肿瘤生物学中的作用,并讨论了他汀类药物和其他胆固醇代谢抑制剂在癌症治疗中的应用,旨在为开发针对胆固醇代谢的抗肿瘤药物以及癌症诊断和治疗的进展提供新的见解。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cce8/12043555/2408808e4b40/12672_2025_2430_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cce8/12043555/8aa361e59f73/12672_2025_2430_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cce8/12043555/2408808e4b40/12672_2025_2430_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cce8/12043555/8aa361e59f73/12672_2025_2430_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cce8/12043555/2408808e4b40/12672_2025_2430_Fig2_HTML.jpg

相似文献

1
Research progress on cholesterol metabolism and tumor therapy.胆固醇代谢与肿瘤治疗的研究进展
Discov Oncol. 2025 Apr 30;16(1):647. doi: 10.1007/s12672-025-02430-5.
2
Cholesterol Metabolic Reprogramming in Cancer and Its Pharmacological Modulation as Therapeutic Strategy.癌症中的胆固醇代谢重编程及其作为治疗策略的药理调节
Front Oncol. 2021 May 24;11:682911. doi: 10.3389/fonc.2021.682911. eCollection 2021.
3
The role of cholesterol metabolism in tumor therapy, from bench to bed.胆固醇代谢在肿瘤治疗中的作用:从实验台到病床
Front Pharmacol. 2023 Apr 6;14:928821. doi: 10.3389/fphar.2023.928821. eCollection 2023.
4
The role of cholesterol metabolism in lung cancer.胆固醇代谢在肺癌中的作用。
Oncol Res. 2024 Sep 18;32(10):1613-1621. doi: 10.32604/or.2024.047933. eCollection 2024.
5
Molecular sources of residual cardiovascular risk, clinical signals, and innovative solutions: relationship with subclinical disease, undertreatment, and poor adherence: implications of new evidence upon optimizing cardiovascular patient outcomes.残余心血管风险的分子来源、临床信号及创新解决方案:与亚临床疾病、治疗不足及依从性差的关系:新证据对优化心血管疾病患者预后的影响
Vasc Health Risk Manag. 2013;9:617-70. doi: 10.2147/VHRM.S37119. Epub 2013 Oct 21.
6
The Role of Cholesterol Metabolism and Its Regulation in Tumor Development.胆固醇代谢及其调节在肿瘤发生中的作用。
Cancer Med. 2025 Apr;14(7):e70783. doi: 10.1002/cam4.70783.
7
RORγ is a context-specific master regulator of cholesterol biosynthesis and an emerging therapeutic target in cancer and autoimmune diseases.RORγ 是胆固醇生物合成的特定背景下的主调控因子,也是癌症和自身免疫性疾病中新兴的治疗靶点。
Biochem Pharmacol. 2022 Feb;196:114725. doi: 10.1016/j.bcp.2021.114725. Epub 2021 Aug 9.
8
[Cholesterol Metabolism and Tumor Immunity].[胆固醇代谢与肿瘤免疫]
Sichuan Da Xue Xue Bao Yi Xue Ban. 2022 Mar;53(2):335-341. doi: 10.12182/20220360202.
9
Targeting lipid reprogramming in the tumor microenvironment by traditional Chinese medicines as a potential cancer treatment.以中药靶向肿瘤微环境中的脂质重编程作为一种潜在的癌症治疗方法。
Heliyon. 2024 May 7;10(9):e30807. doi: 10.1016/j.heliyon.2024.e30807. eCollection 2024 May 15.
10
Cholesterol metabolism in tumor immunity: Mechanisms and therapeutic opportunities for cancer.肿瘤免疫中的胆固醇代谢:癌症的机制与治疗机遇
Biochem Pharmacol. 2025 Apr;234:116802. doi: 10.1016/j.bcp.2025.116802. Epub 2025 Feb 13.

引用本文的文献

1
The Cholesterol Biosynthesis Pathway Plays an Important Role in Chemotherapeutic Drug Response and Metastasis in High-Grade Osteosarcoma.胆固醇生物合成途径在高级别骨肉瘤的化疗药物反应和转移中起重要作用。
Cells. 2025 Jun 29;14(13):993. doi: 10.3390/cells14130993.

本文引用的文献

1
LncRNA PGM5-AS1 Impairs the Resistance of Cervical Cancer to Cisplatin by Regulating the Hippo and PI3K-AKT Pathways.长链非编码RNA PGM5-AS1通过调控Hippo和PI3K-AKT信号通路削弱宫颈癌对顺铂的耐药性。
Biochem Genet. 2024 Dec 28. doi: 10.1007/s10528-024-11011-0.
2
Targeting Mitochondrial Cholesterol Efflux via TCF21/ABCA10 Pathway to Enhance Cisplatin Efficacy in Ovarian Cancer.通过TCF21/ABCA10途径靶向线粒体胆固醇流出以增强顺铂在卵巢癌中的疗效
Biochem Genet. 2024 Oct 22. doi: 10.1007/s10528-024-10939-7.
3
Cholesterol inhibition enhances antitumor response of gilteritinib in lung cancer cells.
胆固醇抑制增强吉特替尼在肺癌细胞中的抗肿瘤反应。
Cell Death Dis. 2024 Sep 30;15(9):704. doi: 10.1038/s41419-024-07082-x.
4
PILRB potentiates the PI3K/AKT signaling pathway and reprograms cholesterol metabolism to drive gastric tumorigenesis and metastasis.PILRB 增强了 PI3K/AKT 信号通路,并重新编程了胆固醇代谢,以推动胃肿瘤发生和转移。
Cell Death Dis. 2024 Sep 3;15(9):642. doi: 10.1038/s41419-024-07026-5.
5
Inhibition of the Sterol Regulatory Element Binding Protein SREBF-1 Overcomes Docetaxel Resistance in Advanced Prostate Cancer.抑制固醇调节元件结合蛋白 SREBF-1 可克服晚期前列腺癌对多西他赛的耐药性。
Am J Pathol. 2024 Nov;194(11):2150-2162. doi: 10.1016/j.ajpath.2024.07.019. Epub 2024 Aug 19.
6
AGFG1 increases cholesterol biosynthesis by disrupting intracellular cholesterol homeostasis to promote PDAC progression.AGFG1 通过破坏细胞内胆固醇稳态来增加胆固醇生物合成,从而促进 PDAC 的进展。
Cancer Lett. 2024 Aug 28;598:217130. doi: 10.1016/j.canlet.2024.217130. Epub 2024 Jul 30.
7
Taxus chinensis var. mairei (Lemée et Lévl) Cheng et L.K. Fu overcomes the resistance to osimertinib in EGFR-mutant non-small-cell lung cancer via suppression of ERK1/2-related cholesterol biosynthesis.中国红豆杉变种曼地亚红豆杉(Lemée et Lévl)Cheng et L.K. Fu 通过抑制 ERK1/2 相关胆固醇生物合成克服 EGFR 突变型非小细胞肺癌对奥希替尼的耐药性。
J Ethnopharmacol. 2024 Nov 15;334:118586. doi: 10.1016/j.jep.2024.118586. Epub 2024 Jul 19.
8
Pitavastatin sensitizes the EGFR-TKI associated resistance in lung cancer by inhibiting YAP/AKT/BAD-BCL-2 pathway.匹伐他汀通过抑制YAP/AKT/BAD-BCL-2通路使肺癌中EGFR-TKI相关耐药性敏感化。
Cancer Cell Int. 2024 Jun 28;24(1):224. doi: 10.1186/s12935-024-03416-z.
9
Gypenoside L inhibits hepatocellular carcinoma by targeting the SREBP2-HMGCS1 axis and enhancing immune response.绞股蓝皂苷 L 通过靶向 SREBP2-HMGCS1 轴和增强免疫反应抑制肝癌。
Bioorg Chem. 2024 Sep;150:107539. doi: 10.1016/j.bioorg.2024.107539. Epub 2024 Jun 8.
10
Activation of the Mevalonate Pathway in Response to Anti-cancer Treatments Drives Glioblastoma Recurrences Through Activation of Rac-1.抗癌治疗引发的甲羟戊酸途径激活通过激活 Rac-1 驱动胶质母细胞瘤复发。
Cancer Res Commun. 2024 Jun 25;4(6):1566-1580. doi: 10.1158/2767-9764.CRC-24-0049.